S-337395 for respiratory syncytial virus infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Oct 2025: Trial registered, NCT07214571
  2. 11 Dec 2025: Trial started, NCT07214571

The trials

NCT07214571: A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

State
Under way
Phase
Phase 2
People
192 planned
Started
11 Dec 2025
Primary completion
30 Dec 2026
Arms
S-337395 High Dose, S-337395 Low Dose
Results
None posted
  1. 9 Oct 2025: Trial registered
  2. 11 Dec 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.